DEA Reschedules CBD Drug for Epilepsy
The DEA has rescheduled the epilepsy cannabidiol drug Epidiolex, paving the way to market for the cannabis-based treatment.
from WebMD Health https://ift.tt/2xWMdBi
Be informed, be entertained!
The DEA has rescheduled the epilepsy cannabidiol drug Epidiolex, paving the way to market for the cannabis-based treatment.
Post a Comment